全文获取类型
收费全文 | 20358篇 |
免费 | 950篇 |
国内免费 | 150篇 |
专业分类
耳鼻咽喉 | 235篇 |
儿科学 | 476篇 |
妇产科学 | 155篇 |
基础医学 | 2642篇 |
口腔科学 | 413篇 |
临床医学 | 1275篇 |
内科学 | 5203篇 |
皮肤病学 | 491篇 |
神经病学 | 1555篇 |
特种医学 | 628篇 |
外科学 | 3454篇 |
综合类 | 53篇 |
一般理论 | 5篇 |
预防医学 | 445篇 |
眼科学 | 641篇 |
药学 | 1345篇 |
中国医学 | 27篇 |
肿瘤学 | 2415篇 |
出版年
2023年 | 106篇 |
2022年 | 91篇 |
2021年 | 440篇 |
2020年 | 241篇 |
2019年 | 310篇 |
2018年 | 400篇 |
2017年 | 317篇 |
2016年 | 417篇 |
2015年 | 474篇 |
2014年 | 582篇 |
2013年 | 709篇 |
2012年 | 1235篇 |
2011年 | 1330篇 |
2010年 | 760篇 |
2009年 | 673篇 |
2008年 | 1155篇 |
2007年 | 1342篇 |
2006年 | 1292篇 |
2005年 | 1408篇 |
2004年 | 1380篇 |
2003年 | 1214篇 |
2002年 | 1248篇 |
2001年 | 335篇 |
2000年 | 291篇 |
1999年 | 346篇 |
1998年 | 292篇 |
1997年 | 218篇 |
1996年 | 206篇 |
1995年 | 207篇 |
1994年 | 180篇 |
1993年 | 195篇 |
1992年 | 224篇 |
1991年 | 193篇 |
1990年 | 160篇 |
1989年 | 159篇 |
1988年 | 144篇 |
1987年 | 141篇 |
1986年 | 127篇 |
1985年 | 117篇 |
1984年 | 91篇 |
1983年 | 71篇 |
1982年 | 56篇 |
1981年 | 53篇 |
1980年 | 47篇 |
1979年 | 67篇 |
1978年 | 48篇 |
1977年 | 41篇 |
1975年 | 31篇 |
1974年 | 40篇 |
1973年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
Masaru Sasaki Tsuyoshi Takahashi Soichiro Funaki Koji Tanaka Yasuhiro Miyazaki Naoko Ose Tomoki Makino Yukinori Kurokawa Makoto Yamasaki Kiyokazu Nakajima Yasushi Shintani Masaki Mori Yuichiro Doki 《Asian journal of endoscopic surgery》2021,14(1):116-119
We report a case of a diaphragmatic hernia after a heart transplant operation. A 43-year-old woman, who underwent orthotropic heart transplantation for hypertrophic cadiomyopathy two year earlier, presented with vomiting and epigastric pain. A computed tomography scan showed that the stomach and transverse colon were dislocated in the left thoracic cavity. We diagnosed left diaphragmatic hernia incarceration and performed laparoscopic repair of the diaphragmatic hernia. A 12 × 8 cm diaphragmatic defect was found intraoperatively on the ventrolateral aspect of the left diaphragm, and the stomach with volvulus had herniated into the thorax through the defect. The hernia was considered to be iatrogenic. The diaphragmatic defect was large, and the diaphragm was thinning. We closed the defect by mesh repair. Laparoscopic mesh repair of the diaphragmatic hernia could be performed safely and with minimal invasiveness. 相似文献
2.
Takaki Shimizu Satoshi Kato Satoru Demura Kazuya Shinmura Noriaki Yokogawa Yuki Kurokawa Noritaka Yonezawa Norihiro Oku Ryo Kitagawa Makoto Handa Ryohei Annen Yoshiyuki Okamoto Hideki Murakami Hiroyuki Tsuchiya 《Journal of orthopaedic science》2021,26(3):327-331
BackgroundLocomotive syndrome is a condition of reduced mobility due to problems with locomotive organs. Although lumbar spinal canal stenosis is one of the major diseases constituting locomotive syndrome, only few studies have focused on the association between the two pathologies. We aimed to investigate the effect of surgery on lumbar spinal canal stenosis with respect to locomotive syndrome using various physical function tests, including locomotive syndrome risk tests, before and after surgery.MethodsClinical data of 101 consecutive patients (male = 46; female = 55; mean age, 69.3 years) who underwent surgery for lumbar spinal canal stenosis at our institute were prospectively collected. Results of physical function tests, including stand-up test, two-step test, and 25-Question Geriatric Locomotive Function Scale, and the sagittal vertical axis were evaluated before and 1 year after surgery. The association between several parameters and improvement of risk level in locomotive syndrome was evaluated.ResultsIn the total assessment, 93.1% of cases were in stage 2 and 6.9% in stage 1 preoperatively, while 72.4% were in stage 2, 22.4% in stage 1, and 5.2% in stage 0 at 1 year postoperatively. Postoperative improvement in the total assessment was observed in 28.7% of cases. Several physical function tests and sagittal vertical axis showed significant improvement after surgery. On multiple logistic regression analysis, age >75 years (odds ratio = 10.9, confidence interval = 1.09–109) and postoperative sagittal vertical axis >40 mm (odds ratio = 17.8, confidence interval = 1.78–177) were significant risk factors associated with non-improvement in risk level of locomotive syndrome.ConclusionsSurgical treatment for lumbar spinal canal stenosis improved physical function, including locomotive syndrome. Risk factors associated with non-improvement of locomotive syndrome were later-stage elderly and postoperative sagittal balance impairment. 相似文献
3.
4.
5.
Takehiko Mori Souichi Shiratori Junji Suzumiya Mineo Kurokawa Motohiro Shindo Uchida Naoyuki Takenaka Katsuto Toshihiro Miyamoto Satoshi Morishige Makoto Hirokawa Takahiro Fukuda Yoshiko Atsuta Ritsuro Suzuki 《Hematological oncology》2020,38(3):266-271
Although allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to provide prolonged remission of relapsed/refractory mycosis fungoides (MF) and Sézary syndrome (SS), its role has not been fully evaluated. Here, the outcomes of allogeneic HSCT for patients with MF/SS were retrospectively evaluated by using the registry database of the Japan Society for Hematopoietic Cell Transplantation. Forty-eight patients were evaluable and enrolled in the analysis. Median age was 45.5 years. Eighteen patients (38%) received myeloablative conditioning, and 33 (69%) received HSCT from an alternative donor. Disease status was complete or partial response in 25% of the patients and relapsed or refractory in the others. At the time of analysis, 18 patients were alive, with a median follow-up of 31.0 months (range, 3.8-31.1). Three-year overall survival (OS) and progression-free survival (PFS) were 30% (95%CI, 16-45%) and 19% (95%CI, 9-31%), respectively. Disease progression was not observed later than 17 months after transplantation. Both disease status and performance status at transplant significantly affected OS and PFS. Although our findings suggest that allogeneic HSCT provides long-term PFS in patients with MF/SS, the timing of transplantation should be decided carefully based on the disease status and the patient's condition in order to improve the outcome. 相似文献
6.
Eo Toriyama Tomoko Hata Kenichi Yokota Masahiko Chiwata Rena Kamijo Miki Hashimoto Masataka Taguchi Makiko Horai Masatoshi Matsuo Emi Matsuo Yumi Takasaki Yasuhisa Kawaguchi Hidehiro Itonaga Shinya Sato Koji Ando Yasushi Sawayama Jun Taguchi Yoshitaka Imaizumi Hideki Tsushima Tatsuro Jo Shinichiro Yoshida Yukiyoshi Moriuchi Yasushi Miyazaki 《Cancer science》2020,111(12):4490
The efficacy of azacitidine (AZA) on survival of lower risk (LR) ‐ myelodysplastic syndromes (MDS) is controversial. To address this issue, we retrospectively evaluated the long‐term survival benefit of AZA for patients with LR‐MDS defined by International Prognostic Scoring System (IPSS). Using data from 489 patients with LR‐MDS in Nagasaki, hematologic responses according to International Working Group 2006 and overall survival (OS) were compared among patients that received best supportive care (BSC), immunosuppressive therapy (IST), erythropoiesis‐stimulating agents (ESA), and AZA. Patients treated with AZA showed complete remission (CR) rate at 11.3%, marrow CR at 1.9%, and any hematologic improvement at 34.0%, with transfusion independence (TI) of red blood cells in 27.3% of patients. and platelet in 20% of patients, respectively. Median OS for patients received IST, ESA, BSC, and AZA (not reached, 91 months, 58 months, and 29 months, respectively) differed significantly (P < .001). Infection‐related severe adverse events were observed in more than 20% of patients treated with AZA. Multivariate analysis showed age, sex, IPSS score at diagnosis, and transfusion dependence were significant for OS, but AZA treatment was not, which maintained even response to AZA, and IPSS risk status at AZA administration was added as factors. We could not find significant survival benefit of AZA treatment for LR‐MDS patients. 相似文献
7.
8.
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis 下载免费PDF全文
9.
10.
Basic fibroblast growth factor‐treated adipose tissue‐derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor 下载免费PDF全文